LINC02056

Across TCGA pan-cancer cohorts, LINC02056 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC02056’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC02056 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02056 is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.

THCA, LUAD, and LUSC are the cancer types where LINC02056 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02056 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	−0.209	<.001	7	view →
LUAD	Female	II,III,IV	−0.216	<.001	5	view →
LUSC	Male	All	−0.200	<.001	5	view →
UCEC	All	All	−0.286	.017	2	view →
PRAD	All	All	−0.179	.003	2	view →
KICH	All	All	−0.149	.038	2	view →
KIRC	Male	II,III,IV	+0.146	.018	2	view →
LIHC	All	All	+0.037	.025	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC02056–THCA

Open the THCA breakdown →